VERY HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER
Clinical trials for VERY HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new VERY HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER trials appear
Sign up with your email to follow new studies for VERY HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Urine DNA test may let some bladder cancer patients stop immunotherapy early
Disease control Recruiting nowThis study tests whether a urine DNA test can help guide when to stop immunotherapy in people with a very high-risk type of bladder cancer that cannot be fully removed by surgery. About 53 participants will receive immunotherapy and then be monitored with urine tests and scans. I…
Matched conditions: VERY HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER
Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Bladder-Sparing hope: immune combo targets tough bladder cancer
Disease control Recruiting nowThis study tests whether adding an immunotherapy drug (toripalimab) to standard BCG therapy can help people with high-risk bladder cancer avoid bladder removal. About 31 participants will receive the combination after surgery. The main goal is to see if the cancer disappears with…
Matched conditions: VERY HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER
Phase: PHASE2 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Pee test could replace painful bladder scopes for cancer patients
Diagnosis Recruiting nowThis study is testing whether a simple urine test that looks for cancer DNA can help decide when patients with high-risk bladder cancer need a cystoscopy (a camera exam of the bladder). Cystoscopy is effective but uncomfortable and can cause infections. The goal is to safely redu…
Matched conditions: VERY HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER
Phase: NA • Sponsor: Tianjin Medical University Second Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC